UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000040959
Receipt number R000046776
Scientific Title Cerebral lateralization of ankle joint position sense in healthy left- and right-side dominant adults studied by functional magnetic resonance imaging
Date of disclosure of the study information 2020/08/01
Last modified on 2021/02/09 12:36:36

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Cerebral lateralization of ankle joint position sense in healthy left- and right-side dominant adults studied by functional magnetic resonance imaging

Acronym

MRIJPS

Scientific Title

Cerebral lateralization of ankle joint position sense in healthy left- and right-side dominant adults studied by functional magnetic resonance imaging

Scientific Title:Acronym

MRIJPS

Region

Japan


Condition

Condition

Healthy people

Classification by specialty

Medicine in general Neurology Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We aim to comprehensively study the neural and behavioral correlates during ankle joint position sense (JPS) tasks in strongly right- or left-side dominant subjects to better understand how the brain processes the lower limbs position sense information.

Basic objectives2

Others

Basic objectives -Others

First, we will examine the laterality of the foot proprioceptive representation in the left-handed participants using two tasks, namely ipsilateral (i.e., memory-based) and contralateral (i.e., interhemispheric transfer) matching tasks to address controversy on their decreased laterality. Second, the degree of proprioceptive laterality in left-handed is going to be compared with that of laterality in other domains, namely the language and face processing to explore the potential common neural foundation of functional laterality across different cognitive domains. Finally, we will explore if such neural laterality in these domains is associated with the individual difference in the high-level social cognitive domain, specifically, the self-transcendence personality trait.

Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

We will adopt a conventional two-level approach for a block-design fMRI data using SPM12. A voxel-by-voxel multiple regression analysis will be conducted for the first-level within-subject (fixed effects) model. We will construct for each subject a model of expected signal changes involving the four conditions; 2 measurement conditions(ipsilateral/contralateral) by 2 foot-laterality conditions(right/left).

Key secondary outcomes

Any deviation from the target position, discounting direction, was defined as the absolute position error:
1) E absolute = ABS(Xparticipant - Xtarget)

For constant error, the difference between reproduced and actual target angle was used, considering the direction of the error:
2) E constant = ( Xparticipant - Xtarget )

3) E variable: The variable error was calculated as the overall standard deviation (SD) of constant error from 14 trials, irrespective of the target range:


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is considered as a block.

Blocking

NO

Concealment

Numbered container method


Intervention

No. of arms

3

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Behavior,custom

Interventions/Control_1

Unilateral and bilateral active motor tasks:

Interventions/Control_2

Ipsilateral matching task:

Interventions/Control_3

Contralateral matching task:

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

40 years-old >=

Gender

Male and Female

Key inclusion criteria

healthy participants
more than 20 years old
left- and right-side dominant

Key exclusion criteria

history of neurological or orthopaedic disorders
other diseases
injury
claustrophobia
anything against performing MRI

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Ryoichi
Middle name
Last name Nagatomi

Organization

Tohoku University

Division name

Division of Biomedical Engineering for Health & Welfare

Zip code

980-8575

Address

2-1, Seiryo-machi, Aoba-ku, Sendai 980-8575, Japan

TEL

8122-717-8588

Email

nagatomi@med.tohoku.ac.jp


Public contact

Name of contact person

1st name Ryoichi
Middle name
Last name Nagatomi

Organization

Tohoku University

Division name

Division of Biomedical Engineering for Health & Welfare

Zip code

980-8575

Address

2-1, Seiryo-machi, Aoba-ku, Sendai 980-8575, Japan

TEL

8122-717-8588

Homepage URL


Email

nagatomi@med.tohoku.ac.jp


Sponsor or person

Institute

Tohoku University

Institute

Department

Personal name



Funding Source

Organization

Tohoku University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committee Tohoku University Graduate School of Medicine

Address

Seiryo-machi 2-1, Aoba-ku, Sendai

Tel

022-717-8007

Email

med-kenkyo@grp.tohoku.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 08 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2020 Year 08 Month 01 Day

Date of IRB

2020 Year 09 Month 18 Day

Anticipated trial start date

2021 Year 04 Month 01 Day

Last follow-up date

2022 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 06 Month 30 Day

Last modified on

2021 Year 02 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046776


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name